| Risk | Moderately High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 2.47% |
| NAV | ₹42.49 (27 May 2020) |
|---|---|
| Fund Started | 19 Apr 2007 |
| Fund Size | ₹747 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.5% |
| Coromandel International Ltd. | Chemicals | Equity | 4.0% |
| Indraprastha Gas Ltd. | Energy | Equity | 4.0% |
| Whirlpool Of India Ltd. | Cons Durable | Equity | 3.6% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 3.3% |
| ICICI Bank Ltd. | Financial | Equity | 3.0% |
| Muthoot Finance Ltd. | Financial | Equity | 2.9% |
| Balkrishna Industries Ltd. | Automobile | Equity | 2.8% |
| Jubilant FoodWorks Ltd. | Services | Equity | 2.7% |
| ICICI Lombard General Insurance Comapny Ltd. | Financial | Equity | 2.7% |
Invesco India Mid Cap Fund Growth is a Equity Mutual Fund Scheme launched by Invesco Mutual Fund. This scheme was made available to investors on 19 Apr 2007. Vinay Paharia is the Current Fund Manager of Invesco India Mid Cap Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹747 Cr and the Latest NAV as of 27 May 2020 is ₹42.49.
The Invesco India Mid Cap Fund Growth is rated Moderately High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 1000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.